Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

iLoF: AI-augmented photonics to identify and quantify disease biomarkers

iLoF

iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery & development. Through advanced AI & photonics, we collect massive amounts of data to build a digital library of biomarkers & biological profiles, bringing together world-class physicists, biologists, & data scientists to...

Funding Programme
Start Date
End Date
Total Funding
€ 2 495 850
European Countries Involved

Impact of Lipid Cell Composition on Beta-Amyloid Aggregation: Exploring Novel Therapeutic Targets for Alzheimer's Disease

ABlina

The ABlina project aims to study how cell membrane lipid composition affects the formation and deposition of beta amyloid (Aβ) aggregates. To achieve this, Molecular Dynamics (MD) simulations will be performed on membranes with varying lipid compositions, focusing on models that mimic senescent and Alzheimer's disease cells. The data generated will...

Funding Programme
Start Date
End Date
Total Funding
€ 191 343
European Countries Involved

In-Touch: Implementation of a person-centered palliative care iNtervention To imprOve comfort, QUality of Life and social engagement of people with advanced dementia in Care Homes

In-Touch

Challenge. Caring for the increasing numbers of people across Europe with advanced dementia and palliative care needs who live in care homes is difficult and demanding. People with advanced dementia can be immobile, non-verbal and unable to take part in day-to-day activities. They can be unsettled or agitated, with low quality-of-life and elevated...

Funding Programme
Start Date
End Date
Total Funding
€ 5 723 637

INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION

PhytoAPP

Under PhytoAPP project it is expected to build new and enhance existing network of international and inter-sectoral cooperation in the form of joint research and innovation activities between the project Partners with multidisciplinary skills and complementary competences in nanomaterials, physics, engineering, green chemistry, biochemistry and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 021 200
European Countries Involved

Integration of AAL Components for Innovative Care Pathways

IntegrAAL

Internet-based and micro technologies have changed the way we live. But elderly people receiving care have not always benefited from these developments. IntegrAAL uses technology to help improve care for older people. Older people are often cared for by many different people, known as a circle of care. This circle may include informal carers as...

Funding Programme
Start Date
End Date
Total Funding
€ 1 200 000
European Countries Involved

MCH/COX2-depend regulation of neuronal function and neuroinflammation in Alzheimer’s disease

SynLip

Alzheimer’s disease (AD) patients stay in a prodromal phase over many years before robust cognitive decline. During this phase, complex molecular events lead to cellular alterations, resulting in aberrant synaptic activity and chronic inflammation which leads to neuronal death and cognitive impairment. My unpublished work, shows that melanin...

Funding Programme
Start Date
End Date
Total Funding
€ 1 567 785
European Countries Involved

MRI based mapping of microscopic brain composition in a mouse model of Alzheimer’s disease

uImaging

This project aims to establish a neuroimaging framework which informs about microscopic brain composition and apply it to study neurodegeneration in a genetic mouse model of Alzheimer’s disease (AD). AD is the most common cause of dementia, characterized by progressive neurodegenerative changes leading to a gradual cognitive loss and memory...

Funding Programme
Start Date
End Date
Total Funding
€ 159 815
European Countries Involved

NANOPARTICLES FOR THERAPY AND DIAGNOSIS OF ALZHEIMER DISEASE

NAD

The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is imperative. It is known that β-amyloid (Aβ) peptide plays a central role in neurodegeneration. In AD brain, Aβ is released in a soluble form that progressively becomes insoluble forming aggregates; extracellular...

Funding Programme
Start Date
End Date
Total Funding
€ 14 365 090

PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.

PANA

Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and limitation of social activities. Progressive aging of EU population will increase the magnitude of this problem in the next decades. Currently, there is not an effective method for the early diagnosis of AD...

Funding Programme
Start Date
End Date
Total Funding
€ 7 775 973
European Countries Involved

Research to Assess Policies and Strategies for Dementia in the Young

RHAPSODY

Dementia is 60 times less common in people aged below 65 years than in older adults. However, when dementia occurs at a relatively young age it imposes a particularly severe burden on patients and families. RHAPSODY attempts to improve the management of young-onset dementia across Europe. The project starts with an analysis how health and social...

Funding Programme
Start Date
End Date
Total Funding
€ 1 805 985
European Countries Involved

Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia

RECOGNISED

In recent years there is mounting evidence that type 2 diabetes (T2D) is associated with cognitive impairment and dementia, which can be considered as a “new” long-term diabetic co-morbid complication with dramatic consequences for patients and their families and a significant impact for healthcare systems. At present there are no reported...

Funding Programme
Start Date
End Date
Total Funding
€ 5 998 273

Structural and biochemical basis of protein amyloid evolution

STAMYEV

Protein misfolding and aggregation into amyloid fibrils is a hallmark of serious diseases such as Alzheimer´s, Familial Amyloidotic Polyneuropathy (FAP) and atherosclerosis. Amyloid fibrils can also be biologically functional. Bacterial and fungal amyloids are proposed to form a prominent protein fold early in evolution. It is unclear why many...

Funding Programme
Start Date
End Date
Total Funding
€ 328 141
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).